DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

Unlocking the Complexity of International Reference Pricing

By: Yulia Privolnev and Roy Moore

Published: May 2016

In seeking to maximize revenue in a given market, pharmaceutical manufacturers must come armed with clinical data, cost metrics, an understanding of the pressure points of payers, and the patience for back and forth negotiation—all in order to build a compelling value message.

What is IRP?

The practice of using the price(s) of a medicine in one or several countries in order to derive a benchmark or reference price for the purposes of setting or negotiating the price of the product in a given country.

Source: WHO Collaborating Centre for Pricing and Reimbursement Policies